Cargando…
Clinical use of CCR5 inhibitors in HIV and beyond
Since the discovery of CCR5 as a coreceptor for HIV entry, there has been interest in blockade of the receptor for treatment and prevention of HIV infection. Although several CCR5 antagonists have been evaluated in clinical trials, only maraviroc has been approved for clinical use in the treatment o...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3105509/ https://www.ncbi.nlm.nih.gov/pubmed/21284908 http://dx.doi.org/10.1186/1479-5876-9-S1-S9 |